MMR Vaccine Proves Effective in Protecting Against Covid-19, Says Study

James Marshall
November 22, 2020

According to a study published in the renowned journal Nature Medicine, people who have recovered from Covid-19 have powerful and protective killer immune cells, even when antibodies are not detectable. "The results also suggest that therapies that target this cytokine combination are candidates for rapid clinical trials for treatment of not only COVID-19, but several other often fatal disorders associated with cytokine storm".

But the results of the study, conducted on a group of United Kingdom healthcare professionals - who are among the most at risk of compromising COVID-19 - indicate that relapse cases are rare.

In various clinical studies, a single MMR II injection produced the vaccine-induced measles hemagglutination-inhibition antibodies in people 95 percent of the time, mumps neutralizing antibodies in 96 percent, and rubella HI antibodies in 99 percent of susceptible persons.

The MMR vaccine could be partly to thank for children's low rate of COVID-19 infections and better prospects for survival. They evaluated them for 30 weeks and found that of the 11,052 study participants who did not have antibodies initially, 89 developed symptomatic COVID-19.

The researchers then followed whether staff who had been infected before had the same number of new Covid-19 infections as those who had not been infected before.

The global criminal police organization, commonly known as Interpol has urged law enforcement agencies worldwide, to be more cautious of Covid-19 contaminated letters which may be used to target political figures, reports NDTV. "It also may explain why children have a much lower Covid-19 case rate than adults, as well as a much lower death rate", said study author Jeffrey E. Gold from the University of Georgia in the US.

Researchers said that staff with antibodies were also less likely to test positive for COVID-19 without symptoms, with 76 without antibodies testing positive, compared to only three with antibodies. Then they exposed all the cells to the coronavirus.

A long-lasting immunity will make administering vaccines much easier, as they would need to be less frequent to keep infections under control. Later, it was observed that most of these individuals had the immune cells to fight against the virus and prevent reinfection.

"If you think of the airways like the high walls that protect a castle, smoking cigarettes is like creating holes in these walls", coauthor Brigitte Gomperts told Reuters.

If the adaptive immune response is powerful enough, it could leave a lasting memory of the infection that will give protection in the future.

The current study involved 560 healthy volunteers, including 240 age 70 or over.

Four produce the symptoms of the common cold and immunity is short-lived. Other side effects may include fever and rash. Part of the reason researchers studied all three diseases was to determine why COVID-19 has spread more rapidly than the earlier diseases.

The study was based on regular coronavirus tests performed on 12,180 health workers at Oxford university hospitals over a 30-week period.

The virus also disrupts cellular systems responsible for secreting substances, the researchers reported on Tuesday in Cell Host & Microbe.

When his team added drugs that affect the cytoskeleton, the virus had trouble making copies of itself, "which indicates to us that the virus needs to reorganise the cytoskeleton in order to replicate with high efficiency", Bartenschlager said.

Other reports by Click Lancashire

Discuss This Article